Skip to main content
English

Suche

  1. Home
  2. Suche

Webseiten-Inhalte

Prostate cancer: Protein identified to reduce tumour growth ... prostate is the second most common cause of cancer death in men. An international study led by Lukas Kenner (MedUni Vienna) and Sabine Lagger (Vetmeduni Vienna) has now identified a protein that could slow tumour growth. The results, which have just been published in the top journal "Molecular Cancer... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2024/default-6e9bbc87ad/prostate-cancer-protein-identified-to-reduce-tumour-growth/
Prostatakrebs: Spezielles Gen weist auf bessere Überlebenschance hin ... der gemeinsamen Arbeit eines Forschungsteams um Monika Oberhuber unter der Leitung von Lukas Kenner vom Institut für Klinische Pathologie der MedUni Wien und des COMET-Forschungszentrums CBmed in Graz konnte anhand einer Datenanalyse nachgewiesen werden, dass ein höheres Vorkommen des Gens PDK4 im... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-im-april-2020/prostatakrebs-spezielles-gen-weist-auf-bessere-ueberlebenschance-hin/
Prostatakrebs: Spezielles Gen weist auf bessere Überlebenschance hin ... der gemeinsamen Arbeit eines Forschungsteams um Monika Oberhuber unter der Leitung von Lukas Kenner vom Institut für Klinische Pathologie der MedUni Wien und des COMET-Forschungszentrums CBmed in Graz konnte anhand einer Datenanalyse nachgewiesen werden, dass ein höheres Vorkommen des Gens PDK4 im... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-im-april-2020/prostatakrebs-spezielles-gen-weist-auf-bessere-ueberlebenschance-hin/medizin-wissenschaft/
Rectal cancer: AF1q could have a tumour-inhibiting effect ... Kenner (Clinical Institute of Pathology) showed that AF1q was significantly more highly expressed in irradiated tumours than in untreated tumours. AF1q is a regulatory protein that is involved in various signalling pathways and plays a role in several cancers. In addition, an association between... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2025/news-in-march-2025/rectal-cancer-af1q-could-have-a-tumour-inhibiting-effect/
Rectal cancer: AF1q could have a tumour-inhibiting effect ... Kenner (Clinical Institute of Pathology) showed that AF1q was significantly more highly expressed in irradiated tumours than in untreated tumours. AF1q is a regulatory protein that is involved in various signalling pathways and plays a role in several cancers. In addition, an association between... https://www.meduniwien.ac.at/web/en/ueber-uns/news/2025/news-in-march-2025/rectal-cancer-af1q-could-have-a-tumour-inhibiting-effect/medicine-science/
Neue Option zur Behandlung von Prostatakrebs erforscht ... Forscher:innen genetisch veränderte Mäuse, bei denen GP130 in der Prostata gezielt aktiviert wurde. „So konnten wir die Reduktion des Tumorwachstums in der Zelle direkt beobachten“, berichtet Lukas Kenner (Klinisches Institut für Pathologie der MedUni Wien), der die Studie gemeinsam mit Stefan Rose-John... https://www.meduniwien.ac.at/web/ueber-uns/news/2024/news-im-november-2024/neue-option-zur-behandlung-von-prostatakrebs-erforscht/
Neue Option zur Behandlung von Prostatakrebs erforscht ... Forscher:innen genetisch veränderte Mäuse, bei denen GP130 in der Prostata gezielt aktiviert wurde. „So konnten wir die Reduktion des Tumorwachstums in der Zelle direkt beobachten“, berichtet Lukas Kenner (Klinisches Institut für Pathologie der MedUni Wien), der die Studie gemeinsam mit Stefan Rose-John... https://www.meduniwien.ac.at/web/ueber-uns/news/2024/news-im-november-2024/neue-option-zur-behandlung-von-prostatakrebs-erforscht/medizin-wissenschaft/
Detailsite | MedUni Vienna ... Lukas Kenner (MedUni Vienna, Vienna University of Veterinary Medicine and Ludwig Boltzmann Institute for Cancer Research) and including colleagues from Graz and from Germany and Japan has for the first time provided experimental proof that, in an animal model, a blockade of IL-6 brings about significant improvements in SLE.In an earlier publication, the working group headed by Lukas Kenner (Pflegerl et al. 2009 in PNAS) was able to show that, in autoimmune diseases such as SLE, the production of Interleukin 6 (IL-6) from dermal keratinocytes plays a key role in the development and progression of the disease... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/discovery-of-a-new-approach-to-the-treatment-of-lupus/
Micro- and nanoplastics in the body are passed on during cell division ... important route for MNPs into the organism. Plastic particles up to the weight of a credit card (approx. five grams) enter the gastrointestinal tract every week. The team led by Verena Pichler (University of Vienna, CBmed) and Lukas Kenner (MedUni Vienna, CBmed, Vetmeduni Vienna) investigated the... https://www.meduniwien.ac.at/web/en/about-us/news/2024/news-in-march-2024/micro-and-nanoplastics-in-the-body-are-passed-on-during-cell-division-1/
Micro- and nanoplastics in the body are passed on during cell division ... important route for MNPs into the organism. Plastic particles up to the weight of a credit card (approx. five grams) enter the gastrointestinal tract every week. The team led by Verena Pichler (University of Vienna, CBmed) and Lukas Kenner (MedUni Vienna, CBmed, Vetmeduni Vienna) investigated the... https://www.meduniwien.ac.at/web/en/about-us/news/2024/news-in-march-2024/micro-and-nanoplastics-in-the-body-are-passed-on-during-cell-division-1/medicine-science/